PRQR

1.0400.95%
BF

Bart Filius

Independent Non-Executive Director

Mr. Bart Filius, MBA, was Non-Executive Director of Idorsia Ltd. since June 13, 2024 until May 6, 2026. He serves as Independent Non-Executive Director at ProQR Therapeutics N.V. since May 2024 and served as its Independent Supervisory Board Member since May 21, 2019. He served as President at Galapagos NV since February 15, 2021 until June 30, 2023 and served as its Chief Operational Officer since September 8, 2017 until June 30, 2023. He served as Chief Financial Officer at Galapagos NV since December 2014 until June 30, 2023. He served as a Member of Management Board at Galapagos NV until April 26, 2022. He had been the Chief Financial Officer of Galapagos NV since December 1, 2014 until March 2021. Mr. Filius serves as Vice President and Chief Financial Officer Sanofi Europe. He has extensive experience at Sanofi. He served as Chief Financial Officer and Country Manager of Sanofi in the Netherlands. Before that, he was Vice President for Mergers & Acquisitions, during which time he led and completed the divestiture of various franchises. He has been Director of Zentiva N.V. since April 3, 2009. Mr. Filius was a strategy consultant at Arthur D. Little. Mr. Filius holds a bachelor's degree in Business from Nyenrode University and master's degree in Business Administration from INSEAD in 1996.

Positions